Overview

Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects of a potent CYP3A4 inhibitor, itraconazole, on the steady-state PK of AVP-923 and AVP-786.
Phase:
Phase 1
Details
Lead Sponsor:
Avanir Pharmaceuticals
Treatments:
Dextromethorphan
Hydroxyitraconazole
Itraconazole
Quinidine